Be a Smart Investor
Tuesday, September 6, 2016
Danaher to buy Cepheid for about $4 billion, including debt
Danaher said it would buy molecular diagnostics company Cepheid in a deal valued at $4 billion, including debt.
from Mergers and Acquisitions http://ift.tt/2bQntlU
No comments:
Post a Comment
Newer Post
Older Post
Home
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment